This study examines the conditional value of high-frequency covariance estimates for minimum-variance portfolio construction in Borsa Istanbul. Using Matriks adjusted 5-minute OHLC data for 11 liquid stocks that were BIST 30 constituents at the beginning of 2017 and have continuous observations over 2017-2025, realized covariance matrices are constructed at 5-minute and 30-minute frequencies. The portfolios are compared with daily-covariance MVPs, an Equal-Weighted benchmark, a buy-and-hold portfolio, and the BIST 30 Total Return Index. The out-of-sample analysis covers 2018-2025 and considers daily and monthly rebalancing, four rolling windows, no short selling, a 20% stock-level cap, and transaction costs of 0.10% for optimized strategies. USD-denominated and inflation-adjusted returns are also examined. Results show that high-frequency covariance estimates do not provide unconditional dominance. Their contribution is concentrated under the 3-month window, where they produce competitive risk-adjusted performance and lower turnover than daily-covariance MVPs at similar volatility levels. The findings suggest that the practical value of high-frequency covariance depends on sampling frequency, estimation window, rebalancing frequency, transaction costs, and benchmark choice.
No takes yet. Share an insight, caveat, or question.
Taner Taş (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: